Oxytocin Versus Misoprostol Plus Oxytocin in the Prevention of Postpartum Hemorrhage at a Semi-Urban Hospital in sub-Saharan Africa: A Retrospective Cohort Study.

International Journal of MCH and AIDS Pub Date : 2020-01-01 Epub Date: 2020-08-30 DOI:10.21106/ijma.365
Emmanuel Numfor, Nkengafac Nyiawung Fobellah, Joel Noutakdie Tochie, Tsi Njim, Sylvester Atanga Ndesso
{"title":"Oxytocin Versus Misoprostol Plus Oxytocin in the Prevention of Postpartum Hemorrhage at a Semi-Urban Hospital in sub-Saharan Africa: A Retrospective Cohort Study.","authors":"Emmanuel Numfor,&nbsp;Nkengafac Nyiawung Fobellah,&nbsp;Joel Noutakdie Tochie,&nbsp;Tsi Njim,&nbsp;Sylvester Atanga Ndesso","doi":"10.21106/ijma.365","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Post-partum hemorrhage (PPH) is a leading cause of maternal mortality. Its first-line of prevention often entails uterotonic drugs like oxytocin and misoprostol which constitute a core point of management in low-resource settings of sub-Saharan Africa. This study aimed to assess the effectiveness of oxytocin alone compared with oxytocin plus misoprostol in two different eras (before and after the advert of misoprostol) of a semi-urban Cameroonian hospital.</p><p><strong>Methods: </strong>This was a retrospective cohort study carried out between January 2015 to April 2015 and between January 2016 to April 2016 on a group of parturients (group A) who received only oxytocin and another administered oxytocin and misoprostol (group B), respectively. All participants delivered at the Bamenda Regional Hospital, Cameroon. The two different periods represent the era before and after the implementation of misoprostol in the prevention of PPH in this semi-urban hospital. Socio-demographic data, clinical characteristics and details of delivery as well as risk factors for PPH were studied from obstetric records.</p><p><strong>Results: </strong>We studied the obstetric records of 1778 parturients were studied; 857 in group A and 879 in group B. Their mean age was 26.3 ±5.2 years. Both groups were comparable in several baseline sociodemographic and clinical characteristics. The prevalence of PPH was 2.7% (3.4% vs 2.2%; p = 0.0744). The risk of PPH in the oxytocin only group was about 1.5 times higher than in the oxytocin plus misoprostol group. The estimated blood loss between the two groups was statistically significant (1100 ± 150 vs 800 ± 100 ml, p< 0.0001). The active management of the third stage of labor without misoprostol was the only risk factor for PPH.</p><p><strong>Conclusion and global health implications: </strong>The implementation of misoprostol plus oxytocin in the prevention of PPH in this low-resource setting improved the obstetrical outcome by reducing the risk and the amount of blood loss during delivery.</p>","PeriodicalId":30480,"journal":{"name":"International Journal of MCH and AIDS","volume":"9 3","pages":"287-296"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/41/74/IJMA-9-287.PMC7472564.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of MCH and AIDS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21106/ijma.365","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/8/30 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Background: Post-partum hemorrhage (PPH) is a leading cause of maternal mortality. Its first-line of prevention often entails uterotonic drugs like oxytocin and misoprostol which constitute a core point of management in low-resource settings of sub-Saharan Africa. This study aimed to assess the effectiveness of oxytocin alone compared with oxytocin plus misoprostol in two different eras (before and after the advert of misoprostol) of a semi-urban Cameroonian hospital.

Methods: This was a retrospective cohort study carried out between January 2015 to April 2015 and between January 2016 to April 2016 on a group of parturients (group A) who received only oxytocin and another administered oxytocin and misoprostol (group B), respectively. All participants delivered at the Bamenda Regional Hospital, Cameroon. The two different periods represent the era before and after the implementation of misoprostol in the prevention of PPH in this semi-urban hospital. Socio-demographic data, clinical characteristics and details of delivery as well as risk factors for PPH were studied from obstetric records.

Results: We studied the obstetric records of 1778 parturients were studied; 857 in group A and 879 in group B. Their mean age was 26.3 ±5.2 years. Both groups were comparable in several baseline sociodemographic and clinical characteristics. The prevalence of PPH was 2.7% (3.4% vs 2.2%; p = 0.0744). The risk of PPH in the oxytocin only group was about 1.5 times higher than in the oxytocin plus misoprostol group. The estimated blood loss between the two groups was statistically significant (1100 ± 150 vs 800 ± 100 ml, p< 0.0001). The active management of the third stage of labor without misoprostol was the only risk factor for PPH.

Conclusion and global health implications: The implementation of misoprostol plus oxytocin in the prevention of PPH in this low-resource setting improved the obstetrical outcome by reducing the risk and the amount of blood loss during delivery.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
催产素与米索前列醇加催产素在撒哈拉以南非洲半城市医院预防产后出血:一项回顾性队列研究。
背景:产后出血(PPH)是孕产妇死亡的主要原因。它的第一线预防通常需要子宫强直药物,如催产素和米索前列醇,这些药物构成了撒哈拉以南非洲资源匮乏地区管理的核心要点。本研究旨在评估在喀麦隆半城市医院的两个不同时期(米索前列醇广告前后)单独使用催产素与催产素加米索前列醇的效果。方法:回顾性队列研究于2015年1月至2015年4月和2016年1月至2016年4月对仅接受催产素的孕妇(a组)和分别给予催产素和米索前列醇的孕妇(B组)进行。所有参与者均在喀麦隆巴门达地区医院分娩。这两个不同的时期代表了米索前列醇在该半城市医院预防PPH实施前后的时代。从产科记录中研究了社会人口统计数据、临床特征和分娩细节以及PPH的危险因素。结果:我们对1778例产妇的产科记录进行了研究;A组857例,b组879例,平均年龄26.3±5.2岁。两组在一些基线社会人口学和临床特征上具有可比性。PPH患病率为2.7% (3.4% vs 2.2%;P = 0.0744)。仅使用催产素组发生PPH的风险比使用催产素加米索前列醇组高1.5倍。两组估计失血量差异有统计学意义(1100±150 vs 800±100 ml, p< 0.0001)。未使用米索前列醇的第三产程的积极管理是PPH的唯一危险因素。结论和全球健康影响:在这种低资源环境中,米索前列醇加催产素预防PPH通过降低分娩过程中的风险和出血量改善了产科结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
16
审稿时长
8 weeks
期刊最新文献
Assessing the Impact of an Intervention on Caregivers' Awareness and Completion of Continuum of Care Among Pregnant Women. Involvement of Male Partners in Sustaining Interventions for Preventing Mother-to-Child Transmission of HIV Among Women with HIV. Immunization Status, Immunization Coverage, and Factors Associated with Immunization Service Utilization Among HIV-Exposed and HIV-Infected Children in India. Oral Manifestations of HIV Infection and Dental Health Needs of Children with HIV Attending HIV Treatment Clinics in Western Cameroon. Cervical Precancer Treatment Outcomes in Cameroon.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1